No NFO data available for this page.
3 Year return
17.5%Investment Details
Calculate Returns
Based on past performance of this fund
Risk Involved
Your principal will be at
Very High Risk
Asset Under Management
₹893.64 Cr.
Expense Ratio
0.83% (inclusive of GST)
Exit Load
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.
Tax Implications
Withdrawal within 1 year
Exit load + 15% tax on gains
Withdrawal after 1 year
10% tax on gains over ₹1 Lakh per financial year
Fund Holdings
Other Holdings | % of Asset |
---|---|
Zydus Lifesci. | 5.03 % |
Divi's Lab. | 4.7 % |
Fortis Health. | 4.2 % |
Apollo Hospitals | 3.92 % |
Alkem Lab | 3.8 % |
Medi Assist Ser. | 2.39 % |
FDC | 2.39 % |
Ajanta Pharma | 2.37 % |
Health.Global | 2.32 % |
Ipca Labs. | 2.14 % |
Orchid Pharma | 2.11 % |
Torrent Pharma. | 2.1 % |
Net CA & Others | 1.8 % |
Sanofi India | 1.79 % |
Jupiter Life Lin | 1.47 % |
Wockhardt | 1.23 % |
Mankind Pharma | 1.1 % |
Aster DM Health. | 1.03 % |
Indoco Remedies | 1.01 % |
Piramal Pharma | 0.96 % |
Medplus Health | 0.93 % |
P & G Health Ltd | 0.88 % |
Syngene Intl. | 0.83 % |
Coromandel Inter | 0.81 % |
Ami Organics | 0.69 % |
Glaxosmi. Pharma | 0.57 % |
Reverse Repo | 0.49 % |
Deepak Nitrite | 0.49 % |
Tata Mutual Fund Managers
MS
Meeta Shetty
Fund Manager since Nov 2018
Fund House Details
Tata Mutual Fund Asset management company
Peer Comparison
Comparison with other similar funds
Funds
|
3 Y Returns
|
ARQ Rating
|
---|---|---|
Invesco India PSU Equity Fund Direct Plan IDCW (Payout / Payout) |
42.14% |
0 |
Quant Infrastructure Fund IDCW Direct Plan Payout |
38.55% |
0 |
Invesco India Infrastructure Fund Direct Plan IDCW (Payout / Payout) |
37.43% |
0 |
Schemes by Tata Mutual Fund
List of mutual fund schemes by AMC
Hybrid . Dynamic Asset Allocation or Balanced Advantage
TATA Balanced Advantage Fund Direct Plan Growth
Hybrid . Dynamic Asset Allocation or Balanced Advantage
TATA Balanced Advantage Fund Direct Plan Payout of IDCW Payout
Hybrid . Arbitrage Fund
TATA Arbitrage Fund Direct Plan Monthly Payout of IDCW Payout
Hybrid . Arbitrage Fund
TATA Arbitrage Fund Direct Plan Monthly Reinvestment of IDCW Reinvestment
Hybrid . Arbitrage Fund
TATA Arbitrage Fund Direct Plan Growth
About TATA India Pharma and Healthcare Fund Direct Plan Growth
The TATA India Pharma and Healthcare Fund Direct Plan Growth is an open-ended equity mutual fund scheme that invests in a portfolio of companies in the Indian pharmaceutical and healthcare sector. The fund aims to generate capital appreciation for its investors by investing in a diversified portfolio of companies in the Indian pharmaceutical and healthcare sector. The fund has been rated as 4-star by CRISIL and is managed by TATA Mutual Fund, one of the leading asset management companies in India.
Investment Objectives of the Scheme
The investment objective of the TATA India Pharma and Healthcare Fund Direct Plan Growth is to generate capital appreciation for its investors by investing in a diversified portfolio of companies in the Indian pharmaceutical and healthcare sector.
Key Features of The Fund
5-year return | 25.92% |
Expense Ratio | 0.83% |
Fund Manager | Meeta Shetty |
Fund Size | ₹893.64 Cr |
Risk Profile | Very High |
Is This Scheme Right for Me?
The TATA India Pharma and Healthcare Fund Direct Plan Growth is a good option for investors who are looking for a long-term investment in the Indian pharmaceutical and healthcare sector. The fund is suitable for investors who have a medium to high risk tolerance and who are looking for a relatively stable investment. However, it is important to note that the fund is not a risk-free investment. The fund's returns can go down as well as up. Investors should only invest in the fund if they are comfortable with the risk of losing money.
AMC Contact Details
Name | Tata Mutual Fund |
Launch Date | March 1994 |
Addresss | Mulla House, Ground Floor, 51, M.G. Road, Near Flora Fountain, Mumbai – 400 001 Maharashtra |
Contact | (022) 6282 7777 |
service@tataamc.com | |
Website | https://www.tatamutualfund.com/ |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.